Challenges in drug development for functional gastrointestinal disorders. Part I: functional dyspepsia.

about

Effectiveness and safety of levosulpiride in the treatment of dysmotility-like functional dyspepsia.Development and validation of a high throughput UPLC-MS/MS method for simultaneous quantification of esomeprazole, rabeprazole and levosulpiride in human plasma.

P2860

Q34589637-82F1CB05-2EAF-4A4D-A6B7-72743B8B7937 Q49260711-6B7503B3-E377-4A21-BA93-DDF4713076CF

P2860

Challenges in drug development for functional gastrointestinal disorders. Part I: functional dyspepsia.

Item

http://www.wikidata.org/entity/Q36455905

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Challenges in drug development ...... Part I: functional dyspepsia.

@ast

Challenges in drug development ...... Part I: functional dyspepsia.

@en

type

Item

label

Challenges in drug development ...... Part I: functional dyspepsia.

@ast

Challenges in drug development ...... Part I: functional dyspepsia.

@en

prefLabel

Challenges in drug development ...... Part I: functional dyspepsia.

@ast

Challenges in drug development ...... Part I: functional dyspepsia.

@en

P1476

Challenges in drug development ...... Part I: functional dyspepsia.

@en

P2093

Andresen V

http://www.w3.org/2001/XMLSchema#string

Camilleri M

http://www.w3.org/2001/XMLSchema#string

P2860

The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study

Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial

Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia.

Prevalence of acid reflux in functional dyspepsia and its association with symptom profile.

Assessment of gastric accommodation: overview and evaluation of current methods.

Pathophysiology and treatment of functional dyspepsia.

Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial.

Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia.

Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying.

A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health.

P304

346-353

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1111/J.1365-2982.2006.00778.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16629861

http://www.w3.org/2001/XMLSchema#string

Challenges in drug development for functional gastrointestinal disorders. Part I: functional dyspepsia.

about

P2860

P2860

Challenges in drug development for functional gastrointestinal disorders. Part I: functional dyspepsia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698